7 unknown. 7 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Unknown 7 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Enterocolitis, Necrotizing: new trials by email Literature Review of Enterocolitis, Necrotizing trials Research Report on Enterocolitis, Necrotizing
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Role of Lactobacillus Reuteri in Preventing Necrotizing Enterocolitis (NEC) in Pre-term Infants Lactobacillus Reuteri DSM 17938, Placebo - Necrotizing Enterocolitis, Sepsis | Phase 2 | Unknown | Children's Hospital and Institute of Child Health, Multan | 120 | 2020-10-01 | 2020-09-09 |
| Prevention of Transfusion Related Acute Gut Injury (TRAGI) in Extremely Low Gestational Age Neonates (ELGANs) Using iNO Inhaled Nitric Oxide, Placebo - Anemia | Phase 1 / Phase 2 | Unknown | New York Medical College | 50 | 2019-02-06 | 2019-04-24 |
| Heat Killed Probiotics in the Prevention of Necrotizing Enterocolitis Heat Inactivated probiotics, Placebo - Necrotizing Enterocolitis, Enterocolitis, Necrotizing | Phase 2 | Unknown | Shaare Zedek Medical Center | 450 | 2016-06-01 | 2016-06-16 |
| Lactated Ringer's Solution in Neonates With Feeding Intolerance Lactated Ringer's Solution - Intestinal Disease, Feeding Disorder Neonatal | Phase 2 | Unknown | McGill University Health Centre/Research Institute of the McGill University Health Centre | 60 | 2010-11-01 | 2011-08-04 |
| Prebiotics in the Prevention of Necrotizing Enterocolitis Galacto-oligosaccharide (GOS), Placebo - Necrotizing Enterocolitis | Phase 2 | Unknown | Shaare Zedek Medical Center | 260 | 2009-07-01 | 2014-01-03 |
| Cysteine Supplementation in Critically Ill Neonates Parenteral cysteine-HCl supplementation, Placebo - added premasol - Sepsis, Bronchopulmonary Dysplasia | Phase 2 / Phase 3 | Unknown | University of California, Los Angeles | 108 | 2006-09-01 | 2010-02-26 |
| Pentoxifylline in the Treatment of NEC in Premature Neonates Pentoxifylline - Necrotizing Enterocolitis | Phase 2 | Unknown | Shaare Zedek Medical Center | 50 | 2005-01-01 | 2008-05-23 |
Premature Birth (3) · Sepsis (2) · Anemia (1) · Bronchopulmonary Dysplasia (1) · Intestinal Diseases (1) · Retinopathy of Prematurity (1) · Systemic Inflammatory Response Syndrome (1)
Digestive System Diseases (7) · Enterocolitis (7) · Gastroenteritis (7) · Gastrointestinal Diseases (7) · Intestinal Diseases (6) · Female Urogenital Diseases and Pregnancy Complications (3) · Obstetric Labor Complications (3) · Obstetric Labor, Premature (3) · Pregnancy Complications (3) · Urogenital Diseases (3) · Infections (2) · Inflammation (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)
4'-galactooligosaccharide (1) · Pentoxifylline (1) · Ringer's Lactate (1) · amino-acid, glucose, and electrolyte solution (1)
Shaare Zedek Medical Center (3) · Children's Hospital and Institute of Child Health, Multan (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · New York Medical College (1) · University of California, Los Angeles (1)
Israel (3) · United States (2) · Canada (1)
Cathy Hammerman, MD (3) · Edmund LaGamma, MD (1) · Gaelle Sadani, MD (1) · Louis Beaumier, MD (1) · Stephen B Shew, M.D. (1)
PMID 22818551, PMID 25104129, PMID 25927273, PMID 26340878, PMID 29906796, PMID 33006765
K08HD052885 (1)